STOCK TITAN

Novavax to Participate in Upcoming March Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Novavax (Nasdaq: NVAX) has announced its management team's upcoming participation in investor conferences scheduled for March. The company will provide access to webcasts of the fireside chat and presentation through their investor relations website at ir.novavax.com. These recordings will remain available for replay for a 30-day period following the conferences.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+17.99% News Effect

On the day this news was published, NVAX gained 17.99%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

GAITHERSBURG, Md., Feb. 27, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), today announced that the management team will participate in the following upcoming investor conferences:

TD Cowen 45th Annual Health Care Conference:

Fireside Chat

Date:

Tuesday, March 4, 2025


Time:

9:10 – 9:40 a.m. Eastern Time (ET)


Location:

Boston, MA


 

Conference

Event:

Investor Meetings


Date:

Tuesday, March 4, 2025



Leerink Partners 2025 Global Healthcare Conference:

Presentation

Date:

Tuesday, March 11, 2025


Time:

3:40 – 4:10 p.m. ET


Location:

Miami Beach, FL


 

Conference

Event:

Investor Meetings


Date:

Tuesday, March 11, 2025





Jefferies Biotech on the Beach Summit:

Conference

Event:

Investor Meetings


Date:

Wednesday, March 12, 2025


Location:

 

Miami Beach, FL

A webcast of the fireside chat and presentation will be available through the Events and Presentations page of the Company's website at ir.novavax.com, with replays available for 30 days after the conferences.

About Novavax

Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most significant health challenges by leveraging its scientific expertise in vaccines and its cutting-edge technology platform, including a protein-based nanoparticle and Matrix-M™ adjuvant. The Company's growth strategy is focused on building new and diversified partnerships via the out-licensing of its technology platform and vaccine assets earlier in the development process. These strategic collaborations are fueled by smart investments in a growing early-stage pipeline starting with the Company's core expertise in infectious disease and potentially expanding into other disease areas. Please visit novavax.com and LinkedIn for more information.

Contacts:
Investors
Luis Sanay, CFA
240-268-2022
ir@novavax.com

Media
Giovanna Chandler
202-709-5563
media@novavax.com

 

Novavax Logo (PRNewsfoto/Novavax)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-upcoming-march-investor-conferences-302387404.html

SOURCE Novavax, Inc.

FAQ

When will Novavax (NVAX) participate in investor conferences?

Novavax will participate in investor conferences in March 2025.

How long will the Novavax (NVAX) March 2025 conference webcasts be available?

The webcasts will be available for replay for 30 days after the conferences.

Where can investors watch Novavax (NVAX) March 2025 conference presentations?

Investors can access the webcasts through the Events and Presentations page at ir.novavax.com

What type of presentations will Novavax (NVAX) deliver at the March 2025 conferences?

The presentations will include a fireside chat and presentation format.
Novavax Inc

NASDAQ:NVAX

NVAX Rankings

NVAX Latest News

NVAX Latest SEC Filings

NVAX Stock Data

1.16B
148.25M
8.76%
58.6%
27.01%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
GAITHERSBURG